Publication

Epithelial Cell Specificity and Apotope Recognition by Serum Autoantibodies in Primary Biliary Cirrhosis

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Guanghua Rong, University of CaliforniaRenqian Zhong, Second Military Medical UniversityAna Lleo, University of CaliforniaPatrick S.C. Leung, University of CaliforniaChristopher L. Bowlus, University of CaliforniaGuo-Xiang Yang, University of CaliforniaChen-Yen Yang, University of CaliforniaRoss L. Coppel, Monash UniversityAftab A Ansari, Emory UniversityDean A. Cuebas, Missouri State UniversityHoward J. Worman, Columbia UniversityPietro Invernizzi, University of CaliforniaGregory J. Gores, The Mayo ClinicGary Norman, INOVA Diagnostics, Inc.Xiao-Song He, University of CaliforniaM. Eric Gershwin, University of California
Language
  • English
Date
  • 2011-07
Publisher
  • Wiley-Blackwell
Publication Version
Copyright Statement
  • © 2011 American Association for the Study of Liver Diseases
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0270-9139
Volume
  • 54
Issue
  • 1
Start Page
  • 196
End Page
  • 203
Grant/Funding Information
  • Financial support provided by National Institutes of Health grant DK39588.
Supplemental Material (URL)
Abstract
  • A major enigma of primary biliary cirrhosis (PBC) is the selective targeting of biliary cells. Our laboratory has reported that following apoptosis human intrahepatic biliary epithelial cells (HiBEC) translocate the E2 subunit of the pyruvate dehydrogenase complex immunologically intact into apoptotic bodies, forming an apotope. However, the cell type and specificity of this reaction has not been fully defined. To address this issue we have investigated whether PDC-E2, BCOADC-E2, OGDC-E2, four additional inner mitochondrial enzymes and four nuclear antigens remain immunologically intact with respect to post-apoptotic translocation in HiBEC and 3 additional control epithelial cells. We report that all three 2-oxo acid dehydrogenase enzymes share the ability to remain intact within the apotope of HiBEC. Interestingly the E2 subunit of the branched chain 2-oxo acid dehydrogenase complex also remained intact in the other cell types tested. We extended the data using 95 AMA+ and 19 AMA- PBC and 76 control sera for reactivity against the 7 mitochondrial proteins studied herein and also the ability of AMA- sera to react with HIBEC apotopes. Sera from 3/95 AMA+ sera, but none of the controls, reacted with 2, 4-dienoyl CoA reductase 1 (DECR1), an enzyme also present intact only in the HiBEC apotope; DECR1 has not been previously associated with any autoimmune disease. Finally the specificity of HIBEC apotope reactivity was confined to AMA+ sera. In conclusion, we submit that the biliary specificity of PBC is secondary to the unique processes of biliary apoptosis.
Author Notes
  • Correspondence: M. Eric Gershwin MD, Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis School of Medicine, Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Suite 6510, Davis, CA 95616; Telephone: 530-752-2884. Fax: 530-752-4669. Email: megershwin@ucdavis.edu. Or Renqian Zhong; rqzhong@yahoo.com
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Pathology

Tools

Relations

In Collection:

Items